Page 2 - Louism Weiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Louism weiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Louism Weiner Today - Breaking & Trending Today

Jounce Therapeutics (NASDAQ:JNCE) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report sent to investors on Thursday. The firm issued a hold rating on the stock. Several other analysts have also commented on the stock. Piper Sandler lowered shares of Jounce Therapeutics from an overweight rating to a neutral rating in […] ....

United Kingdom , Louism Weiner , Piper Sandler , Thomasf Gajewski , Kevinc Tang , Jamesp Allison , Raymond James , Robert Schreiber , Padmanee Sharma , Jounce Therapeutics Inc , Securities Exchange Commission , Balyasny Asset Management , Investment Advisers , Sumitomo Mitsui Financial Group , Connor Clark Lunn Investment Management Ltd , Susquehanna International Group , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Therapeutics Trading Down , Exchange Commission , Director Richard , Asset Management , Lunn Investment Management , International Group , Jounce Therapeutics Daily ,

StockNews.com Initiates Coverage on Jounce Therapeutics (NASDAQ:JNCE)

Investment analysts at StockNews.com started coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a report issued on Thursday. The firm set a “hold” rating on the stock. Other analysts have also recently issued research reports about the stock. Raymond James cut shares of Jounce Therapeutics from an “outperform” rating to a “market […] ....

United Kingdom , Robert Schreiber , Padmanee Sharma , Piper Sandler , Thomasf Gajewski , Jamesp Allison , Louism Weiner , Raymond James , Kevinc Tang , Jounce Therapeutics Company Profile , Sumitomo Mitsui Financial Group , Connor Clark Lunn Investment Management Ltd , Jounce Therapeutics Inc , Renaissance Technologies , Securities Exchange Commission , Balyasny Asset Management , Investment Advisers , Jounce Therapeutics , Get Rating , Therapeutics Trading Down , Director Richard , Exchange Commission , Asset Management , Lunn Investment Management , Jounce Therapeutics Daily , Nasdaq Jnce ,

StockNews.com Initiates Coverage on Jounce Therapeutics (NASDAQ:JNCE)

StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research note issued to investors on Wednesday. The brokerage issued a hold rating on the stock. A number of other analysts have also issued reports on JNCE. Sumitomo Mitsui Financial Group reissued a neutral rating on shares of Jounce Therapeutics in […] ....

United Kingdom , United States , United Kingdom General , Raymond James , Jamesp Allison , Padmanee Sharma , Louism Weiner , Piper Sandler , Kevinc Tang , Thomasf Gajewski , Robert Schreiber , Jounce Therapeutics Company Profile , Millennium Management , Jounce Therapeutics Inc , Blackrock Inc , Health Sciences , Sumitomo Mitsui Financial Group , America Corp , Securities Exchange Commission , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Exchange Commission , Director Richard , Jounce Therapeutics Daily , Nasdaq Jnce ,

Jounce Therapeutics (NASDAQ:JNCE) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a report issued on Monday morning. The brokerage issued a hold rating on the stock. A number of other research analysts have also recently commented on JNCE. Piper Sandler cut shares of Jounce Therapeutics from an overweight rating to a neutral rating […] ....

United Kingdom , Thomasf Gajewski , Kevinc Tang , Robert Schreiber , Raymond James , Piper Sandler , Louism Weiner , Jamesp Allison , Padmanee Sharma , Sumitomo Mitsui Financial Group , Panagora Asset Management Inc , Dimensional Fund Advisors , Charles Schwab Investment Management Inc , Securities Exchange Commission , Prudential Financial Inc , Jounce Therapeutics Inc , Vanguard Group Inc , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Therapeutics Trading Down , Director Richard , Exchange Commission , Asset Management , Fund Advisors , Charles Schwab Investment Management ,

Jounce Therapeutics (NASDAQ:JNCE) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research report released on Monday morning. The brokerage issued a hold rating on the stock. Several other research firms have also issued reports on JNCE. Sumitomo Mitsui Financial Group reissued a neutral rating on shares of Jounce Therapeutics in a report […] ....

United Kingdom , Piper Sandler , Padmanee Sharma , Jamesp Allison , Thomasf Gajewski , Louism Weiner , Raymond James , Robert Schreiber , Kevinc Tang , Susquehanna International Group , Balyasny Asset Management , Jounce Therapeutics Inc , Investment Advisers , Securities Exchange Commission , Connor Clark Lunn Investment Management Ltd , Jounce Therapeutics Company Profile , Sumitomo Mitsui Financial Group , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Director Richard , Exchange Commission , Asset Management , Lunn Investment Management , International Group , Jounce Therapeutics Daily ,